HOME >> BIOLOGY >> NEWS
Rutgers-led consortium awarded $6.5 million by NIH for genomic research

NEW BRUNSWICK/PISCATAWAY, N.J. The National Institute of General Medical Sciences, a unit of the National Institutes of Health (NIH), through its Protein Structures Initiative has awarded more than $6.5 million to a Rutgers-led collaborative research partnership the Northeast Structural Genomics Consortium (NESG).

This one-year grant constitutes the third year of funding for a five-year, $27 million pilot project. Its purpose is to develop technologies required for determining the three-dimensional structure of the wealth of protein molecules whose coding was revealed through the Human Genome Project.

NIH initially funded the five-year project on a year-by-year basis but, based on progress to date, NIH has assured the project's funding for the full five years. NIH has even added a $1.5 million supplement to this year's funding for new robotic equipment that will eliminate a serious process bottleneck in protein sample production.

"Charting these molecular structures will lead us to a clearer understanding of how proteins work and will provide opportunities for the development of new drugs to treat human diseases," said Joseph J. Seneca, university vice president for academic affairs. "Rutgers' leadership role in this major scientific research project affirms the extraordinary expertise and accomplishments of our faculty."

"The completion of the Human Genome Project was not the end of something it was just the beginning, and this is the next big step," said Gaetano Montelione, a resident faculty member of the Center for Advanced Biotechnology and Medicine (CABM) and the principal investigator in the consortium. "Rutgers is the core for one of nine NIH-funded pilot projects in large-scale structural genomics, which have the potential to revolutionize the value and impact of structural biology."

"This outstanding program is very important to the continued growth and development of the center and the life sciences
'"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers, the State University of New Jersey
12-Nov-2002


Page: 1 2 3

Related biology news :

1. Rutgers-led research team finds Hudson River is cleaning itself
2. Rutgers-led researchers discover new photosynthetic bacteria that appear to be significant component of oceans carbon cycle
3. UK-Canadian consortium commits $95 million to international health research project
4. U.S.-German research consortium sequences genome of versatile soil microbe
5. International consortium launches genetic variation mapping project
6. DuPont part of science-based consortium receiving U.S. Dept. of Energy Bio-Refinery grant
7. Harvard Medical School consortium receives grant to harness microbe genomes for environment/energy
8. International consortium to create sequence-ready map of the cattle genome
9. Global consortium announces plans to sequence banana genome
10. Hutchinson Center to lead $11.5 million ovarian-cancer research consortium
11. Ecology of infectious diseases grants awarded

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
(Date:6/23/2020)... ... , ... In its June 22 online post, business and technology news platform ... Ph.D., founder and director of stem cell biotechnology company Asymmetrex . Superb Crew ... starting July 5 it would begin offering free tissue stem cell counting ...
(Date:6/13/2020)... ... June 11, 2020 , ... Bode Technology (Bode), ... forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) continues to deliver ... analysis methods. The team has added experienced genealogists, each having over a decade ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ROCKY HILL, Conn. (PRWEB) , ... June 25, ... ... systems company formed to advance photodynamic therapy for treating cancer, today announced the ... Buffalo, New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights ...
(Date:6/23/2020)... ... , ... Kerafast Inc. , developers of an online ... of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by ... entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. , ...
(Date:6/23/2020)... ... 2020 , ... Regen Suppliers, the one stop shop for ... get the fourth unit free with no limit on the amniotic derived exosomes. ... have been a game changer for regenerative therapies. The products are manufactured at ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... therapies, today announced that it has filed an Investigational New Drug application (IND) ... clinical trial of its lead drug candidate NBTX-001 in patients with panic disorder ...
Breaking Biology Technology:
Cached News: